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Abstract 
Angiogenesis, a highly regulated process, is exploited by tumors like breast cancer to ensure a constant 
supply of oxygen and nutrients and is key for tumor survival and progression. Estrogen and alcohol 
independently have been observed to contribute to angiogenesis in breast cancer but their combinatorial 
effects have never been evaluated. The exact mechanism by which estrogen and alcohol contribute to 
breast cancer angiogenesis remains to be elucidated. In this study, we defined the in vitro effects of the 
combination of estrogen and alcohol in breast cancer angiogenesis using the tubulogenesis and scratch 
wound assays. Conditioned media, generated by culturing the murine mammary cancer cell line, TG1-1, 
in estrogen and ethanol, enhanced tubule formation and migration as well as modulated the MAP Kinase 
pathway in the murine endothelial cell line, SVEC4-10. Additionally, estrogen and ethanol in combination 
enhanced the expression of the pro-angiogenic factors VEGF, MMP-9, and eNOS, and modulated Akt 
activation. These observations suggest that TG1-1 cells secrete pro-angiogenic molecules in response to 
the combination of estrogen and ethanol that modulate the morphological and migratory properties of 
endothelial cells. The data presented in this study, is the first in attempting to link the cooperative activity 
between estrogen and ethanol in breast cancer progression, underscoring correlations first made by 
epidemiological observations linking the two. 
Key words: breast cancer, angiogenesis, estrogen, alcohol, ethanol 
Introduction 
Breast cancer remains one of the most commonly 
occurring cancers in women. The estimated breast 
cancer cases and deaths in 2018 stand at 268,670 and 
41,400 respectively; making it second only to lung 
cancer in the number of cancer related deaths in the 
United States of America1. Factors known to influence 
the development of breast cancer include genetics, 
evidenced by the positive association between breast 
cancer and mutated BRCA1 and BRCA2 genes2–4, and 
the female sex hormone, estrogen5–7. In addition to its 
essential physiological roles, estrogen is known to 
sustain breast cancer development and progression 
by enhancing cell viability and motility8. The actions 
of estrogen are primarily initiated by its binding to 
estrogen receptor alpha (ERα), resulting in the 
activation of key cellular signaling pathways 
including the MAPK, NFκB and AP-1 pathways9,10. 
Other long-known risk factors for breast cancer 
include early menarche, late menopause, age at first 
birth, intervals between births as well as number of 
births, all of which implicate estrogen exposure as a 
key factor for breast cancer development11–15. This led 
to the development of anti-estrogens like tamoxifen as 
a mainstay treatment strategy for breast cancer. 
Anti-estrogens like tamoxifen, in addition to 
inhibiting the various cellular effects of estrogen, have 
been demonstrated to inhibit angiogenesis, promoting 
a better prognosis in treated patients, and enhanced 
cell death in animal models16–19. 
Interestingly, in addition to the aforementioned 
risk factors, epidemiological observations positively 
correlate breast cancer incidence with alcohol 
consumption. A meta-analysis of 53 epidemiological 








cancer and 95,067 healthy controls demonstrated a 
consistently higher relative risk of breast cancer in the 
alcohol consuming group. Moreover, the relative risk 
increased with increasing levels of alcohol intake20. 
Another meta-analysis spanning 33 years revealed a 
similar result and estimated that an average of one 
drink per day leads to a monotonic 10% rise in breast 
cancer risk21. On the molecular level, experimental 
studies have suggested that by-products of ethanol 
metabolism, namely acetaldehyde, play a role in 
increasing oxidative stress, epigenetic changes, and 
DNA damage, thus promoting tumor develop-
ment22,23. A study by Williams et al evaluating risk of 
invasive breast cancer in women who consume 
alcohol demonstrated an increased risk in invasive 
breast cancer in certain populations that drank more 
than 7 alcoholic beverages per week24 Although 
epidemiological studies link alcohol and increased 
breast cancer incidence, a concrete mechanism is yet 
to be established.  
A significant observation was made wherein 
increased risk and incidence of breast cancer was 
positively correlated in women with ER positive 
breast cancer who reported increased alcohol 
consumption25–27. This observation was further 
corroborated in a study, that included 38,454 women, 
and observed a positive correlation between breast 
cancer risk and moderate alcohol consumption in 
postmenopausal women on hormone replacement 
therapy25,28. Together, these studies provide anecdotal 
evidence suggesting a relationship between alcohol 
and estrogen that promotes breast cancer; however, 
the mechanisms regulating this risk have not been 
fully elucidated.  
One biological mechanism that is targeted by 
both alcohol and estrogen in tumors is angiogenesis; a 
process indispensable for tumor growth and 
progression. Ethanol consumption has been 
demonstrated to promote mammary tumor growth, 
leading to increased cellular proliferation and 
enhanced expression of VEGF, an essential protein 
involved in angiogenesis29,30. Estrogen, over and 
above increasing viability and proliferation of breast 
cancer cells via the ER-alpha pathway, is also known 
to promote endothelial cell activity; consequently neo 
vascularization and angiogenesis 8,31. We reported 
earlier that estrogen mobilizes endothelial progenitor 
cells (EPCs) from the bone marrow to the tumor site 
thus increasing breast tumor tissue neo- 
vascularization32.  
Based on our current knowledge we speculate 
that a cooperative mechanism exists between estrogen 
and alcohol which acts to increase angiogenesis. To 
date, studies addressing this interaction between 
estrogen and alcohol on neo-vascularization in breast 
cancer have not been undertaken. This formed the 
basis for this study; an effort to explain a mechanism 
for this potential relationship between alcohol and 
estrogen in enhancing angiogenesis. We hypothesized 
that both alcohol and estrogen play complementary 
roles to enhance angiogenesis in breast cancer, 
thereby promoting it. To that end, we used in vitro 
model systems to explore the effects of ethanol, 
estrogen and a combination of the two on both a 
murine mammary cancer cell line, TG1-1, and a 
murine endothelial cell line, SVEC4-10. Treated TG1-1 
cells were assayed for the effect of either estrogen, 
ethanol, or their combination on expression of various 
pro-angiogenic factors, as well as the effects on the 
PI3K/Akt cell-signaling pathway. In addition, 
conditioned media from treated TG1-1 cells was 
harvested and used to determine the effects of TG1-1 
secretory factors on SVEC4-10 cells. To that end, 
SVEC4-10 cells were cultured in TG1-1 conditioned 
media after which tubulogenesis, migration, 
proliferation and activation of relevant signaling 
pathways was assayed for. This study, the first of its 
kind, demonstrates an enhanced expression of 
angiogenic markers when cells are treated with a 
combination of alcohol and estrogen. 
Materials and Methods 
Cell Culture and Treatments 
The TG1-1 murine mammary cancer cell line33, a 
kind gift from Dr. Rakesh Jain (Harvard University), 
was developed from spontaneous tumors in 
transgenic FVB mice expressing the c-neu oncogene 
under the control of the mouse mammary tumor virus 
promoter. SVEC4-10, a murine endothelial cell line, 
was purchased from ATCC (CRL-2181). Both cell lines 
were maintained in complete 1X DMEM (Corning 
#10-013-CV) supplemented with 10% (v/v) Fetal 
Bovine Serum (FBS) (BioTC #FBS-02), 2mM 
L-glutamine (Corning #25-005-CI), 1X 
penicillin/streptomycin (P/S) (Corning #30-002-CI) 
and 25μg/ml Plasmocin prophylactic (Invivogen 
#ant-mpp). For ethanol treatments, TG1-1 cells were 
incubated with 200 proof absolute ethanol (Fisher 
Scientific #BP2818-100) at a concentration of 0.2% and 
0.5%, since physiologically relevant doses are set to be 
at 0.3%34. For estrogen treatment, TG1-1 cells were 
incubated with β-estradiol (Sigma #E8875-1G) at a 
concentration of 10-8 M. Treatments were carried out 
for 24 hours either in combination or as stand-alone 
treatments. SVEC4-10 cells were treated for 24 hours 
with the conditioned media generated from alcohol 
and/or estrogen treated TG1-1 cells. 
Conditioned Media Experiments 
Conditioned media was generated by treating 




TG1-1 cells with 0.2% or 0.5% ethanol and/or 10-8M 
estrogen in starvation media; phenol red free RPMI 
(Corning #17-105-CV) containing 5% charcoal 
stripped FBS (Sigma #F6765) and 1X P/S. The media 
was collected at the end of 24 hours, centrifuged to 
remove cell debris, and stored at -80oC until further 
use. SVEC4-10 cells were plated in complete DMEM. 
Once 70% confluence was reached, the SVEC4-10 cells 
were incubated in starvation media overnight. The 
following day, starvation media was removed and 
TG1-1 conditioned media added to the SVEC4-10 cells 
and incubated for 24 hours. At the end of 24 hours, 
cells were lysed and whole cell lysates analyzed for 
protein expression by western blots. 
Western Blot 
Whole cell lysates were made from TG1-1 and 
SVEC4-10 cells using RIPA buffer (50 mM Tris-HCl, 
pH 7.4, 150 mM NaCl, 0.2% sodium deoxycholate, 
0.1% SDS, 0.5% NP-40) supplemented with HALT 
protease/phosphatase inhibitor cocktail 
(Thermofisher #78440). Samples were placed on ice 
for 45 minutes with intermittent vortexing. The 
lysates were then centrifuged for 20 minutes at 14000 
rpm at 4oC. Protein concentrations were determined 
using the Bio-rad Protein Assay Dye Reagent 
Concentrate (Bio-Rad #5000006). Fifteen micrograms 
of total protein were loaded per sample and resolved 
on 10% SDS gels under reducing conditions and 
transferred onto Immobilon-P membranes (Millipore 
#IPVH00010) at 220mA for 2 hours at 4oC. 
Membranes were blocked using 5% dried milk in 1X 
TBST (200mM Tris–HCl, 150mM NaCl, pH 7.4, and 
0.1% Tween-20 added fresh/liter of 1XTBS (TBS-T)) 
for 2 hours on a shaker at room temperature. They 
were incubated with primary antibodies (VEGF, 
eNOS, MAPK, AKT, MEK, FAK) overnight at a 1:1000 
dilution (unless indicated otherwise) in 2% bovine 
serum albumin made in 1X TBST at 4oC. The next day, 
membranes were washed three times with 1X TBST, 
followed by incubation with horse radish peroxidase 
conjugated secondary antibodies, made at a 1:10,000 
dilution in 2% dried milk in 1X TBST, for 2 hours, on a 
shaker, at room temperature. After 4 washes in 
1XTBST, the membrane was developed using Pierce 
ECL western blotting substrate (Thermofisher 
#32106), and detected on CL-Xposure Film 
(Thermofisher #34091). Films were scanned and band 
intensity analyzed using the ImageJ Software. 
Tubulogenesis Assay 
Twenty four well plates were coated with 
100μl/well of growth factor reduced matrigel 
(Corning #356231) and incubated for 30 minutes at 
37oC to enable polymerization. Overnight starved 
SVEC4-10 cells were re-suspended in treated or 
untreated TG1-1 conditioned media as well as 
unconditioned starvation media and complete DMEM 
as controls, and plated at 50,000 cells in 500μl/well. 
The plates were incubated overnight. The following 
day, excess media was carefully removed and 
tubulogenesis observed under the microscope in 
bright field at 500X magnification. Four fields of view 
were counted per well (2 wells/treatment). Using 
Image J’s Angiogenesis Analyzer toolset, the number 
of master segments and total segment length were 
determined for each field of view and averaged.  
XTT Assay 
SVEC4-10 cells were plated at 10,000 cells/well 
in a 96 well plate and allowed to adhere overnight. 
The next day, starvation media was added and the 
cells were starved for 14-18 hours after which the 
starvation media was replaced by TG1-1 conditioned 
media as well as unconditioned starvation media and 
complete DMEM serving as controls. Twenty four 
hours post treatment, conditioned media was 
removed and 100µl serum free clear DMEM 
containing 25µl of the XTT (Thermo Fisher #X6493) 
reagent (1mg/ml) with 25mM Phenazine 
Methosulfate (PMS) (Fisher Scientific #AC130160010) 
was added to each well. The plate was incubated at 
37oC for 4 hours and OD was measured at 450nm with 
a reference wavelength of 630nm.  
Scratch Wound (Migration) Assay 
SVEC4-10 cells were plated at 500,000 cells/well 
in a 6 well plate and incubated until a 60% confluent 
monolayer was observed. Subsequently, the cells 
were starved for 14-18 hours in starvation media 
followed by treatment with TG1-1 conditioned media 
for 24 hours. Prior to start of the treatment, two 
vertical wounds were created using a 20µl sterile 
pipette tip. Horizontal lines were made, using a 
sharpie, on the underside of the plate to allow for 
visualization at the same spots at 0 hours and 24 hours 
post treatment. Pictures were taken in the bright field 
phase contrast at 100X magnification, and migration 
distance calculated using the scale on the microscope. 
Statistical Analysis 
Data was normalized to estrogen treatment 
groups. The ethanol and estrogen combination 
treatments were compared to the estrogen 
stand-alone treatment using a Student’s T Test where 
possible; P<0.05 was considered to be statistically 
significant. Error bars on all figures represent 
standard error of mean. 





SVEC4-10 cells demonstrate enhanced 
tubulogenesis when cultured in conditioned 
media obtained from estrogen and alcohol 
treated TG1-1 cells.  
Previous observations by our laboratory 
demonstrated that estrogen stimulates bone marrow 
derived endothelial progenitor cell (BM-EPCs) 
migration from the bone marrow thus resulting in 
enhanced neo-vascularization in breast cancer32. 
Based on our observations, and other groups29,35–38 
stating that ethanol can influence angiogenesis, we 
sought to determine if estrogen and ethanol in 
combination act to enhance angiogenesis in breast 
cancer, by using an in vitro tubulogenesis assay. In 
addition to recruitment from the bone marrow, 
angiogenesis is a complex process determined by the 
ability of endothelial cells to differentiate and form 
stable tubules in response to pro-angiogenic factors. 
In an effort to mimic the tumor microenvironment, 
conditioned media from TG1-1 cells treated with 
ethanol, in the presence and absence of estrogen, as 
well as estrogen alone, was added onto SVEC4-10 
cells for 24 hours. Enhanced tubule formation was 
observed in SVEC4-10 cells when treated with 
conditioned media generated (Fig 1A) in presence of a 
combination of ethanol at a concentration of 0.2% or 
0.5% with estrogen as compared to estrogen alone. 
This was further quantified; number of master 
segments formed (Fig 1B) and the total segment 
length (Fig 1C) determined. There was an increase in 
the number of master segments as well as total 
segment length, commonly used to represent the 
extent of tubulogenesis39,40. Our results provide 
evidence that TG1-1 cells, treated with estrogen and 
alcohol in combination presumably secrete 
pro-angiogenic factors which result in increased 
SVEC4-10 endothelial cell differentiation and 
formation of stable tubules on a basement membrane 
matrix. 
Ethanol enhances estrogen mediated 
expression of pro-angiogenic markers in 
TG1-1 breast cancer cells.  
Angiogenesis is a dynamic process that requires 
the interplay between various pro-angiogenic factors, 
which are required both in vivo and in vitro, such as 
that observed during tubule formation41. Vascular 
endothelial growth factor (VEGF), is considered to be 
the most important pro-angiogenic factor, playing a 
critical role in angiogenesis30,42–44. In order to 
determine the levels of VEGF protein expression that 
could have contributed to the enhanced tubulogenesis 
observed, TG1-1 whole cell lysates were used and 
levels of VEGF determined by a western blot analysis 
(Fig 2A). We observed an increase in the expression 
 
Figure 1. Enhanced Tubulogenesis in SVEC4-10 cells in presence of alcohol and estrogen A) Representative brightfield images (50X) of SVEC4-10 cells 
cultured in alcohol (Ethanol/EtOH) and/or estrogen (10-8M) treated TG1-1 conditioned media; B) Number of master segments, and C) Total Segment Length in 
pixels, analyzed using angiogenesis analyzer by Image J. (n=2) Error bars represent ±SEM. 




levels of VEGF protein when TG1-1 cells were treated 
with a combination of ethanol at 0.2% and 0.5% and 
estrogen, in a dose dependent manner, compared 
with estrogen treatment alone. Another molecule that 
plays an important role in angiogenesis is endothelial 
nitric oxide synthase (eNOS)45–49. eNOS on converting 
L-arginine to L-citrulline produces nitric oxide (NO) 
which plays a crucial role in vascular remodeling and 
maintaining a vasodilatory tone50–52. We assessed the 
expression of eNOS in treated Tg1-1 cells, which was 
similar to that observed in VEGF. Enhanced eNOS 
expression was observed when TG1-1 cells were 
treated with a combination of ethanol at 0.2% and 
0.5% and estrogen compared to estrogen alone (Fig 
2B). In addition to VEGF and eNOS, we assessed the 
expression of MMP-9, which belongs to a family of 
proteins collectively known as matrix 
metalloproteinases. Matrix metalloproteinases play a 
role in the proteolytic degradation of the extracellular 
matrix leading to tumor invasion, metastasis, as well 
as tissue remodeling that occurs during angiogenesis 
as observed in many cancers53–56. Expression of 
MMP-9 in TG1-1 cells (Fig 2C) was greatly enhanced 
upon treating the cells with a combination of ethanol, 
at 0.2%, 0.5% as well as 1.0%, and estrogen, in a dose 
dependent manner, when compared to estrogen 
alone. Taken together these results demonstrate that 
ethanol and estrogen enhance the expression of 
pro-angiogenic and ECM remodeling factors in tumor 
cells, which are in part responsible for the stimulated 
proliferation and differentiation of endothelial cells 
and thus, angiogenesis.  
Ethanol and estrogen induced TG1-1 secretory 
factors enhance activation of MAP kinase cell 
survival pathway in SVEC4-10 cells  
The MAPK pathway has a wide array of 
downstream effector molecules that affect cellular 
functions, such as cell proliferation, differentiation, 
and cell survival, which has been observed to play a 
role in angiogenesis57–59. In order to evaluate if 
secretory factors from treated TG1-1 cells would lead 
to activation of the MAPK pathway in SVEC4-10 cells, 
we treated the cells with conditioned media harvested 
from TG1-1 cell cultures followed by western blot 
analyses. The MAPK pathway targets assayed for 
were Mek/pMek and MAPK/pMAPK (Fig 3A and B). 
There was an upregulation of activation of MEK1/2, 
as denoted by the p-MEK/MEK ratio (Fig 3A), in 
SVEC4-10 cells cultured in conditioned media 
generated from TG1-1 cells treated with a 
combination of 0.2%, 0.5% and 1.0% ethanol and 
estrogen as compared to estrogen alone. Surprisingly, 
this increase in MEK1/2 activation did not carry on 
downstream to its effector, MAPK, as no major 
differences were noted in expression of 
MAPK/pMAPK (Fig 3B). One plausible explanation 
is that there may be a regulating factor playing a role, 
which may be a result of an inhibitory 
phosphorylation of MEK1 by cdk560. 
 
 
Figure 2. Enhanced pro-angiogenic factor expression in TG1-1 breast 
cancer cells in presence of alcohol and estrogen Western blot analysis of 
whole cell lysates from TG1-1 cells treated with Ethanol and Estrogen. Whole 
cell lysates were assayed for expression of A) VEGF; B) eNOS and C) MMP-9. 
Expression was determined by normalizing to TG1-1 protein lysates treated 
with estrogen alone (n=3) Error bars represent ±SEM a Student T test was 
performed. *p<0.05, **p<0.01 
 
Ethanol and estrogen induced TG1-1 secretory 
factors enhance expression of the cellular 
migration mediator FAK in SVEC4-10 Cells 
Endothelial focal adhesion kinase (FAK), 
induced by VEGF, plays a critical role during tumor 
angiogenesis, as it is involved in cell signaling via the 




PI3 Kinase/Akt signaling pathway and maintaining 
endothelial cell adhesion during angiogenesis61–64. 
The importance of FAK in angiogenesis was also 
observed in experiments using FAK knockout mice in 
which angiogenesis was inhibited63,65. We evaluated 
the expression of FAK in SVEC4-10 cells upon 
treatment with TG1-1 conditioned media. FAK 
expression in SVEC4-10 cells was enhanced in a dose 
dependent manner upon culturing the cells with CM 
derived from TG1-1 cells treated with a combination 
of ethanol and estrogen as compared to estrogen 
alone (Fig 4). These data indicate that enhanced FAK 
expression could play a role in endothelial cell 
migration by modulating cytoskeletal proteins, such 
as actin and microtubules, which are both directly 
involved in cell motility.66,67  
 
 
Figure 3. Enhanced MEK Activation in SVEC4-10 cells in the 
presence of alcohol and estrogen Western blot analysis from whole cell 
lysates of SVEC4-10 cells cultured in conditioned media from ethanol and 
estrogen treated TG1-1 cells. Whole cell lysates were assayed for expression of 
A) MEK Activation; and B) MAPK Activation. Expression was determined by 
normalizing to SVEC4-10 protein lysates treated with TG1-1 conditioned media 
cultured in the presence of estrogen alone (n=2) Error bars represent ±SEM. 
 
Ethanol and estrogen induced TG1-1 secretory 
factors enhance migration but not 
proliferation in SVEC4-10 cells  
In order to evaluate the migratory potential of 
SVEC4-10 cells in presence of ethanol and estrogen 
treated TG1-1 conditioned media, we performed a 
scratch wound assay. Treating SVEC4-10 cells with 
secretory factors of ethanol and estrogen treated 
TG1-1 cells demonstrated an enhanced migration 
compared to ethanol or estrogen alone, as observed by 
the scratch wound results. In presence of conditioned 
media generated with 0.2% and 0.5% ethanol in 
combination with estrogen, the wound closed by 
300µm and 400μm respectively. This migration was 
higher as compared to conditioned media generated 
by treating TG1-1 cells with ethanol alone, where the 
wound closed by 100μm for both 0.2% and 0.5% and 
estrogen alone, where the wound closed by 200μm 
(Fig 5A). Migration and proliferation form the two 
foundation pillars for successful angiogenesis and 
frequently occur simultaneously during 
angiogenesis68–70. To evaluate the effects of TG1-1 
secretory factors on proliferation of SVEC4-10 cells, 
we performed an XTT Proliferation assay on 
SVEC4-10 cells cultured in the presence of Tg1-1 
conditioned media. Surprisingly, no striking 
differences in cell proliferation were observed when 
comparing the different treatment conditions (Fig 5B). 
These data indicate that TG1-1 secretory factors 
enhance migration of endothelial cells in presence of 
ethanol and estrogen in combination. 
 
 
Figure 4. Alcohol and estrogen enhance expression of FAK in 
SVEC4-10 cells. Western blot analysis from whole cell lysates of SVEC4-10 
cells cultured in conditioned media from ethanol and estrogen treated TG1-1 
cells. Whole cell lysates were assayed for expression of FAK, a marker for 
migration. Expression was determined by normalizing to SVEC4-10 protein 
lysates treated with TG1-1 conditioned media cultured in the presence of 
estrogen alone (n=2) Error bars represent ±SEM. 
 
Ethanol and estrogen enhance activation of 
the pro-survival PI3K/AKT signaling pathway 
in TG1-1 breast cancer cells  
We have provided evidence that treating TG1-1 
breast cancer cells with a combination of ethanol and 
estrogen leads to an increase in the expression of 
pro-angiogenic factors. Interestingly, the 
pro-angiogenic factors (VEGF, MMP-9, and eNOS) 
assayed for in this study require the PI3K/Akt 
signaling pathway, amongst other signaling 
pathways, to control their expression71–75. Addition-
ally, AKT phosphorylation leads to the activation of 




pro-survival pathways leading to enhanced cancer 
progression8,76,77. We thus wanted to evaluate the 
effects of ethanol and estrogen on activation of Akt in 
TG1-1 cells when treated with a combination of 
ethanol and estrogen. Following treatment of TG1-1 
cells, whole cell lysates were prepared followed by 
western blot analyses in order to determine the 
expression of AKT and phosphorylated Akt (Fig 6). 
Treatment of TG1-1 cells with a combination of 0.5% 
and 1.0% ethanol and estrogen led to enhanced 
activation of AKT compared to estrogen alone.  
Discussion 
Angiogenesis is a highly regulated process 
exploited by tumors in order to sustain their growth 
and development, ultimately providing the necessary 
vasculature needed for metastasis30,78,79. Various 
factors, such as estrogen and ethanol have been 
shown to modulate angiogenesis. Our laboratory has 
demonstrated that estrogen mobilizes bone marrow 
derived endothelial progenitor cells (BM-EPCs) thus 
resulting in increased neo-vascularization of 
mammary tumor tissue in mice32. Studies have 
demonstrated that ethanol as well is directly linked to 
the process of angiogenesis by means of increasing the 
expression of VEGF, monocyte chemoattractant 
protein 1 (MCP-1), and hypoxia inducible factor 1 
alpha (HIF-1α)29,38. Interestingly, despite the available 
literature, no studies have been undertaken to address 
the possible correlation between estrogen and 
ethanol, in combination, on the process of angiogen-
esis. This comes as a surprise being that literature 
exists in which epidemiological observations have 
been made linking estrogen and alcohol in increasing 






Figure 5. SVEC4-10 cell migration is enhanced in the presence of alcohol and estrogen. A) Representative bright field (100X) image of a scratch wound 
assay using SVEC4-10 cells in presence of conditioned media from ethanol and estrogen treated TG1-1 cells for 24 hours, demonstrating enhanced migration in 
presence of ethanol and estrogen. (n=2) B) XTT assay using SVEC4-10 cells cultured in presence of conditioned media from ethanol and estrogen treated TG1-1 cells 
for 24 hours (n=3) Error bars represent ±SEM. 
 
 





Figure 6. Enhanced pro-survival pathway activation in TG1-1 breast 
cancer cells in presence of ethanol and estrogen Western blot analysis 
using whole cell lysates from TG1-1 cells treated with Ethanol and Estrogen. 
Expression of activated Akt was determined by normalizing to protein lysates 
from TG1-1 cells treated with estrogen alone (n=3) Error bars represent ±SEM. 
 
In this study we demonstrate, for the first time, 
that ethanol enhances estrogen-mediated angio-
genesis in breast cancer using the estrogen responsive 
murine mammary cancer cell line, TG1-1, and the 
murine endothelial cell line, SVEC4-10. Expression of 
pro-angiogenic molecules is regulated by multiple cell 
signaling pathways, including the PI3K/Akt 
pathway, which is known to play a prominent role in 
angiogenesis72,77,82. We observed an enhanced 
activation of the PI3K/Akt pathway, as determined 
by the phosphorylation status of Akt in TG1-1 when 
treated with estrogen and ethanol. The enhanced 
expression of Akt/pAkt observed in response to both 
ethanol and estrogen correlates with the enhanced 
expression of pro-angiogenic factors observed in 
figure 2. Activation of the PI3K/Akt pathway in 
tumor cells is known in literature to modulate 
expression of various pro-angiogenic factors72,73,77. 
Treatment of TG1-1 cells in the combination of 
estrogen and ethanol resulted in an enhanced 
expression of VEGF, eNOS, and MMP-9 compared to 
treatment with either estrogen or ethanol alone.  
Vascular endothelial growth factor (VEGF) plays 
a pivotal role in tumor angiogenesis43,44,46,83. VEGF is 
also known to function in an autocrine signaling loop 
in hormone responsive cancers84–87 and activate 
endothelial nitric oxide synthase (eNOS).83 Expression 
of eNOS is classically restricted to the vascular 
endothelium but has been shown to be expressed in 
cancers and is positively correlated with cancer 
aggressiveness88,89. The enhanced expression of eNOS 
that we observed in response to both estrogen and 
ethanol could be caused, in part, by the autocrine 
function of VEGF. Lastly, we observed a substantial 
increase in the expression of MMP-9 in TG1-1 cells 
upon treatment with the combination of estrogen and 
ethanol, compared to either estrogen or ethanol alone. 
Tumor derived matrix metalloproteinase 9 (MMP-9) 
has been known to play a crucial role in tumor 
progression, tissue remodeling, and angiogenesis90–92. 
The Williams study demonstrated an increased 
invasive breast cancer risk in women who drink more 
than 7 alcoholic drinks per week24. MMP-9 has been 
shown to lead to proteolytic activation of TGFβ, 
consequently leading to increased invasion as well as 
angiogenesis90,93, and release of VEGF from ovarian 
cancer cells94. Based on these observations, we 
conclude that ethanol and estrogen, in combination, 
result in activation of the PI3K/Akt pathway, which 
results in enhanced expression of pro-angiogenic 
molecules. We speculate that increased MMP9 as a 
result of the combination of estrogen and ethanol 
points to increased invasiveness; however this needs 
to be evaluated further.  
Having assayed for the expression of various 
pro-angiogenic factors, we focused our attention on 
characterization of SVEC4-10 endothelial cells in 
response to conditioned media generated by culturing 
TG1-1 in estrogen and ethanol. The two parameters 
that we assayed for were tubulogenesis, a direct 
measure of angiogenesis in vitro, and SVEC4-10 
migration and proliferation. We observed increased 
tubule formation in SVEC4-10 endothelial cells 
treated with conditioned media generated from TG1-1 
cells cultured in a combination of ethanol and 
estrogen, when compared to TG1-1 cells cultured in 
either estrogen or ethanol alone. We evaluated 
migration using the classical scratch wound assay. As 
with tubulogenesis, enhanced migration of SVEC4-10 
cells was observed when cultured in conditioned 
media obtained from TG1-1 cultured in both ethanol 
and estrogen together but, no differences in SVEC4-10 
proliferation were observed under the same 
experimental conditions. 
The observations made with respect to enhanced 
tubulogenesis and migration of SVEC4-10 cells 
prompted us to explore the MAP-Kinase pathway, as 
is it known to have numerous downstream effectors 
that target cellular processes including proliferation, 
migration and survival.57 Surprisingly, our data 
indicate that the media generated from TG1-1 cells 
treated with a combination of ethanol and estrogen, 
while demonstrating enhanced MEK activation, failed 
to translate into activation of its downstream effector 
MAPK. We believe that this is a phenomenon 
observed due to the role of cdk5 in angiogenesis. 
Cdk5 is known to mediate endothelial cell 
migration95. Phosphorylation of MEK1 by Cdk5, has 
been demonstrated to lead to its inactivation and thus 
a downregulation of MAPK activation, pushing cells 
towards a more migratory phenotype60. Keeping this 
in mind, it was not surprising when we observed an 
enhanced migratory capacity in the SVEC4-10 cell 
plated in ethanol and estrogen treated TG1-1 




conditioned media, but no proliferation differences. 
Lastly, to validate enhanced migratory capacity of 
SVEC4-10 cells, we assayed for the expression of focal 
adhesion kinase (FAK) in response to TG1-1 
conditioned media. Enhanced expression of FAK was 
also observed in cells cultured in conditioned media 
generated from both ethanol and estrogen treated 
TG1-1 cells. This is significant as FAK associates with 
paxillin and cellular integrins leading to enhanced 
endothelial cell migration63,96,97.  
The possible mechanism we propose in outlined 
in Figure 7, in which the enhanced angiogenic events 
are initiated by activated AKT in response to both 
estrogen and ethanol, thus leading to the secretion of 
pro-angiogenic factors from TG1-1 murine breast 
cancer cells. In turn, these pro-angiogenic factors act 
upon SVEC-4-10 murine endothelial cells, resulting in 
enhanced activation of the MAP kinase pro-survival 
pathway and FAK expression, consequently 
enhancing cellular migration and tubulogenesis. 
Thus, the experimental observations made in 
this study support various epidemiological 
observations in that increased alcohol consumption in 
post-menopausal women on estrogen replacement 
therapy have an increased risk of developing breast 
cancer. We demonstrate that alcohol acts as a 
promoter of estrogen driven biological processes 
observed in breast cancer. Specifically, we propose a 
mechanism by which estrogen and alcohol, in 
combination, can lead to enhanced angiogenesis in 
breast cancer. The mechanism reported in this study 
may indirectly be responsible for the increased risk of 
breast cancer associated with these women, 
supporting the later stages that involve a sustained 
blood supply via angiogenesis. This study does not 
limit itself to post-menopausal women; in 
premenopausal women, increased alcohol intake 
could also enhance various estrogen mediated 
processes as well as enhance the risk of developing 
estrogen responsive cancers. 
 A potentially different pro angiogenic 
mechanism may be via the NMDA glutamate 
receptor. The NMDA receptor, vital for cancer 
survival and growth is known to be expressed on 
various cancer cells including the estrogen responsive 
MCF-7 breast cancer cells98–101. Estrogen is known to 
upregulate the expression and activity of this receptor 
in the central nervous tissue102,103. One can speculate 
that it may have a similar effect on estrogen 
responsive breast cancer cells. Ethanol has also been 
demonstrated to upregulate NMDA receptor 
expression104. This study opens up multiple avenues 
for further exploration. Alcohol metabolism begins 
with the conversion of alcohol to acetaldehyde by the 
enzymatic action of alcohol dehydrogenase105. 
Alcohol dehydrogenase activity is known to be lower 
in women than in men, leading to a higher blood 
alcohol level in women106. This prolonged exposure 
could potentiate the pro-tumorigenic effect seen in 
breast cancer patients. Additionally, the effects of 
acetaldehyde in combination with estrogen remain to 
be studied. This study does not include the kinetics 
and effects of alcohol metabolites in 
combination with estrogen, an 
important future direction to pursue. 
Our lab has established an in vivo 
model linking estrogen to enhanced 
angiogenesis using the estrogen 
responsive TG1-1 breast cancer cell 
line32. Based on our previous study, 
we are now planning on performing 
animal studies aimed at addressing 
the systemic effects of estrogen and 
ethanol on breast cancer 
angiogenesis; the concentration of 
ethanol in serum and tumor tissue 
and the effect of both on 
angiogenesis in breast cancer. Our 
study opens up a new area of 
exploration into other components of 
the tumor microenvironment, such 
as macrophages. Anti-inflammatory 
tumor associated M2 macrophages 
play a role in angiogenesis and 
tumor progression107–109.and, can be 
studied in presence of both ethanol 
 
 
Figure 7. Proposed model TG1-1 cells, in presence of ethanol and estrogen, activate its pro-survival 
AKT pathway, leading to enhanced secretion of pro-angiogenic factors, such as VEGF, eNOS and MMP9. 
These proangiogenic factors in turn act on SVEC4-10 endothelial cells resulting in enhanced activation of 
MEK thus leading to increased endothelial cell migration and tubulogenesis. Overall, the events described 
consequently lead to enhanced breast cancer angiogenesis and progression. 




and estrogen. This will provide novel intervention 
strategies that target alcohol metabolism pathways in 
an effort to dampen angiogenesis and improve patient 
prognosis.  
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